Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Iridex Corp changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of IRIX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders22222+2
Shares2.83M284.8K2.79M+239.5K (+9.4%)
Value$3.24M$325.7K$3.19M+$269.1K (+9.2%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Iridex Corp at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to IRIX in Q4 2025
InstitutionSharesValue% of portfolio
Weber Capital Management LLC259,558$295.9K0.28%
United Capital Financial Advisers, LLC65,529$74.7K0.00%
Thompson Davis & Co., Inc.28,500$32.5K0.02%
Diversify Advisory Services, LLC19,134$27.0K0.00%

Sold out (2)

Institutions that held Iridex Corp at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of IRIX in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Centiva Capital, LP18,768$21.6K
Tower Research Capital LLC (TRC)501$571

Not filed for Q4 2025 yet (2)

Institutions that held Iridex Corp at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IRIX in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
AMH Equity Ltd184,230$210.1K
Apexium Financial, LP100,529$115.6K